Celgene Quanticel Research, Inc.
Records under this name other than the patents Celgene Quanticel Research, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 112 patents it holds.
Showing 1 to 8 of 8 · Back to Celgene Quanticel Research, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,896,436 | Histone demethylase inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,870,634 | Histone Demethylase Inhibitors Held by another company In force · Medium confidence | In force | Medium confidence | |
| US 10,112,940 | Histone Demethylase Inhibitors Lapsed on the fee record Ended Oct 30, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 30, 2026 | Low confidence |
| US 11,464,771 | Bromodomain and Extra-Terminal Protein Inhibitor Combination Therapy Lapsed on the fee record Ended Oct 11, 2026 · Medium confidence | Lapsed on the fee record | Ended Oct 11, 2026 | Medium confidence |
| US 10,626,103 | Inhibitor of lysine specific demethylase-1 Lapsed on the fee record Ended Apr 21, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 21, 2024 | USPTO record |
| US 10,626,104 | Inhibitors of lysine specific demethylase-1 Lapsed on the fee record Ended Apr 21, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 21, 2024 | USPTO record |
| US 10,597,376 | Inhibitors of lysine specific demethylase-1 Lapsed on the fee record Ended Mar 24, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 24, 2024 | USPTO record |
| US 10,543,198 | Inhibitor of lysine specific demethylase-1 Lapsed on the fee record Ended Jan 28, 2024 · USPTO record | Lapsed on the fee record | Ended Jan 28, 2024 | USPTO record |